Supplementary Methods, Figure Legends from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Shinan Li,Rui Sun,Yongyan Chen,Wei H,Zhigang Tian

DOI: https://doi.org/10.1158/0008-5472.22407825

2023-01-01

Abstract:Supplemental Materials and Methods and Figure Legends

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Wenqun Zhong,Zhang Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23952936.v1

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure 5 from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Shinan Li,Rui Sun,Yongyan Chen,Wei H,Zhigang Tian

DOI: https://doi.org/10.1158/0008-5472.22407831.v1

2023-01-01

Abstract:S. Fig. 5. IL-18 silencing inhibits MDSC accumulation and restores T cell function.
Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Dong‐Tsamn Lin,Lei,Yonghao Liu,Yinsheng Zhang,Bo Hu,Guirong Bao,Songliu Yuan,Jin Zou,Chunliang Liu,Miao Yu,Dedy Sandikin,Yan Wu,Lei Zhao,Yu X,Haiyan Liu

DOI: https://doi.org/10.1158/0008-5472.22408238

2023-01-01

Abstract:Supplemental figure legends
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Methods and Figure legends from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Shilpak Chatterjee,Krishnamurthy Thyagarajan,Pravin Kesarwani,Jin H. Song,Myroslawa Soloshchenko,Jianing Fu,Stefanie R. Bailey,Chenthamarkshan Vasu,Andrew S. Kraft,Chrystal M. Paulos,Xue-Zhong Yu,Shikhar Mehrotra

DOI: https://doi.org/10.1158/0008-5472.22403504

2023-01-01

Abstract:<p>The document contains supplementary methods and figure legends for supplementary figure 1, 2 and 3.</p>
Supplementary Methods, Tables 1 - 2, Figure Legend from Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions Via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

Xiaodong Sun,Qiangjun Sui,Cai Zhang,Zhigang Tian,Jian Zhang

DOI: https://doi.org/10.1158/1535-7163.22501288

2023-01-01

Abstract:PDF file - 130K, Supplementary Table 1 Fluorochrome-conjugated antibodies used in flow cytometry.; Supplementary Table 2 Primers used in PCR.
Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964576.v1

2024-01-01

Abstract:Supplementary materials and methods
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Bryan Wei Chen,Wei Chen,Hui Liang,Hao Liu,Chao Liang,Xiao Zhi,Li-qiang Hu,Xia-Zhen Yu,Tao Wei,Tao Ma,Fei Xue,Lei Zheng,Bin Zhao,Xin-Hua Feng,Xue-li Bai,Ting-bo Liang

DOI: https://doi.org/10.1158/1535-7163.22502419

2023-01-01

Abstract:Supplemental Materials and Methods and Supplemental Figure Legends
Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu,Xue Bai,Jian Wang,Xiaonan Tang,Dehua Wu,Shasha Du,Xiu-Ju Du,Yao-Wei Zhang,Hai‐Liang Zhu,Yuan Fang,Zhimou Guo,Qiandong Zeng,Xuejun Guo,Zhu Li,Zhong‐Yi Dong

DOI: https://doi.org/10.1158/1078-0432.22471917.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Xing Huang,Qi Zhang,Yu Lou,Junli Wang,Xinyu Zhao,Lin Wang,Xiaozhen Zhang,Shanshan Li,Yulan Zhao,Qi Chen,Tingbo Liang,Xueli Bai

DOI: https://doi.org/10.1158/2326-6066.22542108

2023-01-01

Abstract:Supplementary Materials and Methods, and Supplementary Figure legends.
Supplementary Figure 4 from Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18

Zhiliang Ma,Wen Li,Shinichi Yoshiya,Yong Xu,Masaki Hara,Yosif El‐Darawish,Tzvetanka Markova,Kyosuke Yamanishi,Hiromichi Yamanishi,Hideaki Tahara,Yoshimasa Tanaka,Haruki Okamura

DOI: https://doi.org/10.1158/1078-0432.22459815.v1

2023-01-01

Abstract:Cytotoxic activity exhibited by PECs from pre-implanted mice receiving immune checkpoint blockade and/or IL-18
Supplementary Figure and Table Legends from Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer

Hong Liu,Yiyang Xu,Jingyi Xiang,Long Li,Shon Green,Zhaohui Yang,Bryan Zimdahl,Jingwei Lu,Neal Cheng,Lucas H. Horan,Bin Liu,Shuicheng Yan,Pei Wang,Juan Díaz,Lü Jin,Yukiko Nakano,Javier F. Morales,Pengbo Zhang,Lian-xing Liu,Binnaz K. Staley,Saul J. Priceman,Christine E. Brown,Stephen J. Forman,Vivien W. Chan,Cheng Liu

DOI: https://doi.org/10.1158/1078-0432.22467774

2023-01-01

Abstract:Figure Legends for Sup. Figures 1-9 and Sup. Table 1
Supplementary Materials and Methods, Tables and Figure Legends from A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy

Chuanzhen Yang,Weicheng Zang,Zefang Tang,Yapeng Ji,Ruidan Xu,Yongfeng Yang,Aiping Luo,Bin Hu,Zemin Zhang,Zhihua Liu,Xiaofeng Zheng

DOI: https://doi.org/10.1158/0008-5472.22417212

2023-01-01

Abstract:Supplementary Materials and Methods, Tables S1-2, and Figure legends
Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964573.v1

2024-01-01

Abstract:The Supplementary Data consist of: Supplementary Tables S1-7
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplemental Data from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402070.v1

2023-01-01

Abstract:Supplemental materials and methods and legends for all supplemental figures.
Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Peng Yuan,Xiao-Hong He,Ye-Fei Rong,Jing Cao,Yong Li,Yun-Ping Hu,Yingbin Liu,Dangsheng Li,Wenhui Lou,Mo-Fang Liu

DOI: https://doi.org/10.1158/0008-5472.22413540.v1

2023-01-01

Abstract:This file contains Materials and Methods that are involved in the figures of the main text and supplementary information. These materials and methods include information of plasmid constructs, cell transfection and viral transduction, RNA preparation and qRT-PCR, luciferase reporter assay, ChIP assay, therapeutic experiments in mice, and immunohistochemistry and in situ hybridization.
Supplementary Methods and Figure Legends from Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade

Alexandra Eichten,Jia Su,Alexander P. Adler,Li Zhang,Ella Ioffe,Asma A. Parveen,George D. Yancopoulos,John Rudge,Israel Lowy,Hsin Chieh Lin,Douglas MacDonald,Christopher Daly,Xunbao Duan,Gavin Thurston

DOI: https://doi.org/10.1158/0008-5472.22411524.v1

2023-01-01

Abstract:Supplementary methods and figure legends

Supplementary Methods, Figure Legends from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Supplementary Figure 5 from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Methods and Figure legends from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Supplementary Methods, Tables 1 - 2, Figure Legend from Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions Via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Supplementary Figure 4 from Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18

Supplementary Figure and Table Legends from Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer

Supplementary Materials and Methods, Tables and Figure Legends from A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy

Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplemental Data from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Methods and Figure Legends from Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade